Medplus Healthcare Services looks to raise ₹1,639 crore via IPO

• Pharmacy retail chain Medplus Healthcare Services filed a draft red herring prospectus (DRHP) with SEBI to raise ₹1,639 crore through IPO.
• The company offers both offline and online sales of pharmaceutical products through website and mobile application.
• The company offers a wide range of products, including pharmaceutical and wellness products and fast-moving consumer goods.
• Azim Premji’s PI Opportunities Fund is among promoters in the company selling its shares through the IPO.

Hyderabad-based pharmacy retail chain Medplus Healthcare Services has filed the draft red herring prospectus (DRHP) with India’s market regulator to raise ₹1,639 crore through an initial public offering (IPO).

The offer comprises ₹600 crore of fresh issue and an offer for sale (OFS) of ₹1,039 crore by existing promoters. Promoter Lone Furrow Investments will sell equity shares worth ₹450 crore through the IPO issue followed by ₹500 crore by PI Opportunities fund, which is an affiliate of PremjiInvest. PremjiInvest is the family office of billionaire Azim Premji, chairman of Wipro.

The company sells a wide range of products, including pharmaceutical and wellness products -- medicines, vitamins, medical devices and test kits, and fast-moving consumer goods -- home and personal care products, toiletries, baby care products, soaps and detergents, and sanitisers.

The 15-year-old company was founded by Gangadi Madhukar Reddy, managing director and chief executive officer, with the vision “to set up a trusted pharmacy retail brand that offers genuine medicines and delivers better value to the customer by reducing inefficiencies in the supply chain using technology,” the company said in its DRHP filing.

It has grown from operating 48 stores in Hyderabad to now operating a retail network of over 2,000 stores across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, as of March, 2021.


The company offers both offline and online sales of pharmaceutical products through website and mobile application.

Medplus Healthcare Services intends to use ₹467 crore from the IPO proceeds for working capital requirements of its subsidiary Optival Health Solutions and the rest for general corporate purposes.

SEE ALSO: Walmart to prioritise Flipkart’s Diwali sale ‘Big Billion Days’

Apollo Hospitals gives multibagger returns in last one year on growth in pharmacy business, vaccination revenue